OmnicellFRA:OC9 76 OCF Margin % is 17.59% as of Mar. 2026, which is 21% above its 10-year median of 14.50. GuruFocus rates FRA:OC9 with a GF Score™ of 76/100 and a GF Value™ of €32.99. The stock has 6 warning signs investors should review. Among 667 Healthcare Providers & Services companies, Omnicell ranks better than 62.07% on this metric.
The historical rank and industry rank for Omnicell's OCF Margin % or its related term are showing as below:
FRA:OC9'
s OCF Margin % Range Over the Past 10 Years
Min: 3.48 Med: 14.5 Max: 20.83
Current: 12.75
During the past 13 years, the highest OCF Margin % of Omnicell was 20.83%. The lowest was 3.48%. And the median was 14.50%.
FRA:OC9's OCF Margin % is ranked better than 62.07% of 667
companies
in the Healthcare Providers & Services industry
Industry Median: 8.27
vs FRA:OC9: 12.75
Omnicell OCF Margin % Related Terms
Omnicell OCF Margin % Historical Data
* Premium members only.
The historical data trend for Omnicell's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:OC9 vs TDOC, SDGR, OMDA: OCF Margin % Comparison
For the Health Information Services subindustry, Omnicell's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Omnicell OCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Omnicell's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Omnicell's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Omnicell (FRA:OC9) has a OCF Margin % of 17.59% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Omnicell and its competitors. This is 21% above median its historical median of 14.50. Over the past decade, Omnicell's OCF Margin % has ranged from 3.48 to 20.83. According to the industry distribution chart, Omnicell ranks #253 out of 667 companies in the Healthcare Providers & Services industry, placing it in the top 37.9%.
Is Omnicell's OCF Margin % too high?
Omnicell's current OCF Margin % of 17.59% is 21% above median its 10-year median of 14.50. Over the past 10 years, this metric has ranged from a low of 3.48 to a high of 20.83. The Healthcare Providers & Services industry median OCF Margin % is 8.27. Omnicell's value of 17.59% is 112.7% above this industry median. Based on the distribution chart, Omnicell ranks #253 out of 667 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Omnicell has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Omnicell's OCF Margin % compare to TDOC and SDGR?
According to the Healthcare Providers & Services industry distribution chart, Omnicell ranks #253 out of 667 companies for OCF Margin %. This puts Omnicell in the upper half of its industry. The industry median OCF Margin % is 8.27. Omnicell's value of 17.59% is 112.7% above this benchmark. Historically, Omnicell's own OCF Margin % has ranged from 3.48 to 20.83 over the past decade. While the company's 10-year median is 14.50 vs. the industry median of 8.27, Omnicell has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.27, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Omnicell's current OCF Margin % of 17.59% is 112.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Omnicell and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Omnicell's current OCF Margin % is 17.59%, which is 21% above median its own 10-year median of 14.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omnicell stock overvalued right now?
Omnicell (FRA:OC9) has a current OCF Margin % of 17.59%. The stock's GF Value™ is €32.99, compared to a current price of €38.80 — trading 17.6% above its estimated fair value. The current OCF Margin % is 17.59%, which is 21% above median its 10-year median of 14.50 and 112.7% above the Healthcare Providers & Services industry median of 8.27. Omnicell's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Omnicell (FRA:OC9), the current OCF Margin % is 17.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Omnicell (FRA:OC9) Overvalued in 2026?
Based on GuruFocus' analysis, Omnicell stock appears to be overvalued.
The current stock price of €38.80 is trading 17.6% above its estimated GF Value™ of €32.99.
Key valuation signals for FRA:OC9:
OCF Margin %: 17.59% (21% above median its 10-year median of 14.50)
GF Value™: €32.99 vs. price of €38.80 (17.6% above fair value)
Industry Position: 112.7% above the Healthcare Providers & Services median (#253 of 667)
No single metric tells the full story. See the FRA:OC9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
76GF Score
Get the complete analysis for FRA:OC9
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:OC9 has been successfully added to your 
